Lymphoma Trial, Recruiting (NCT03458520)

Lymphoma Trial, Recruiting NCT03458520 Sponsor: Stanford University Condition: Lymphoma

Printed from Voxsanity (voxsanity.com.au) — NCT03458520 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lymphoma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have a confirmed solid tumor, or you have a newly found growth that doctors strongly believe is a solid tumor.
You have leukemia and doctors are concerned there may be a specific area of abnormality in one of your organs (confirm with trial site).
If you are under 18, your parent or guardian is willing to sign a consent form; if you are 18 or older, you are willing to sign a consent form yourself.

Who may not be able to join:

You have a medical reason why you cannot have an MRI or PET/MR scan — for example, if you have a heart pacemaker, certain metal clips in your brain, or a blood sugar level above 200 mg/dl.
If you are under 18, your parent or guardian is not willing to give permission; if you are 18 or older, you are not willing to give your own consent.
Your tumor started in the brain or central nervous system (such as the spinal cord).
You are currently pregnant, or the patient is an unborn baby.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 16 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Heike Daldrup-Link, MD, Stanford University

Phone: 650-720-8601

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03458520

Sponsor: Stanford University

Phase: Not Applicable

Status: Recruiting

Condition: Lymphoma

Trial contact: 650-720-8601

More information: https://clinicaltrials.gov/study/NCT03458520

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have a confirmed solid tumor, or you have a newly found growth that doctors strongly believe is a solid tumor.
You have leukemia and doctors are concerned there may be a specific area of abnormality in one of your organs (confirm with trial site).
If you are under 18, your parent or guardian is willing to sign a consent form; if you are 18 or older, you are willing to sign a consent form yourself.

Who may not be able to join:

You have a medical reason why you cannot have an MRI or PET/MR scan — for example, if you have a heart pacemaker, certain metal clips in your brain, or a blood sugar level above 200 mg/dl.
If you are under 18, your parent or guardian is not willing to give permission; if you are 18 or older, you are not willing to give your own consent.
Your tumor started in the brain or central nervous system (such as the spinal cord).
You are currently pregnant, or the patient is an unborn baby.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 16 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Stanford University

Registry

ClinicalTrials.gov

Start date

1 February 2018

Est. completion

31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of tumors

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov